SynthesisFrontiers in oncology2024

First-line immunotherapy efficacy in advanced squamous non-small cell lung cancer with PD-L1 expression ≥50%: a network meta-analysis of randomized controlled trials.

Wei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.